Semaglutide is a GLP-1 receptor agonist that suppresses appetite, delays gastric emptying, and improves glucose-dependent insulin secretion
This means that any athlete subject to WADA regulations (which includes most high-level sports in Australia, overseen by Sport Integrity Australia) is strictly prohibited from using BPC-157 at any time, both in- and out-of-competition
Overall, 56 female and 34 male participants received 48 mg of cysteine peptides daily
Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes